Variant report
Variant | esv3336288 |
---|---|
Chromosome Location | chr4:86070199-86070552 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558379079 | chr4:86070202-86070203 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs79620024 | chr4:86070211-86070212 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs76143787 | chr4:86070225-86070226 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543888159 | chr4:86070273-86070274 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs534461169 | chr4:86070286-86070287 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139150675 | chr4:86070365-86070366 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1316405 | chr4:86070374-86070375 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs149497752 | chr4:86070375-86070376 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573719877 | chr4:86070377-86070378 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556222091 | chr4:86070417-86070418 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs182167538 | chr4:86070444-86070445 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545676049 | chr4:86070475-86070476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Prostate cancer | 16573809 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:86069200-86070600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
2 | chr4:86069200-86070800 | Weak transcription | NHEK | skin |
3 | chr4:86069400-86070400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr4:86069400-86070800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr4:86069400-86070800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr4:86069600-86073000 | Weak transcription | Brain Inferior Temporal Lobe | brain |
7 | chr4:86069800-86074200 | Enhancers | HSMM | muscle |
8 | chr4:86070000-86070200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
9 | chr4:86070000-86073200 | Enhancers | HSMMtube | muscle |
10 | chr4:86070400-86071200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |